0,845  0,004  Caspase 3 stimulant
0,795  0,017  Apoptosis agonist
0,779  0,018  Antiinflammatory
0,763  0,013  Antineoplastic (breast cancer)
0,751  0,005  Antioxidant
0,758  0,012  Antineoplastic (lung cancer)
0,748  0,005  Antineoplastic (glioma)
0,746  0,004  Antineoplastic (brain cancer)
0,743  0,005  Cardioprotectant
0,737  0,005  NOS2 expression inhibitor
0,729  0,005  Antimitotic
0,727  0,005  5 Hydroxytryptamine release stimulant
0,709  0,006  Cardiovascular analeptic
0,715  0,013  Antineoplastic (colorectal cancer)
0,711  0,013  Antineoplastic (colon cancer)
0,688  0,012  Alzheimer's disease treatment
0,676  0,015  Antileukemic
0,683  0,023  Transcription factor NF kappa B inhibitor
0,655  0,007  Nitric oxide antagonist
0,652  0,006  Free radical scavenger
0,644  0,014  Prostate cancer treatment
0,627  0,004  ICAM1 expression inhibitor
0,631  0,012  Chemopreventive
0,648  0,030  Caspase 9 stimulant
0,634  0,019  15-Lipoxygenase inhibitor
0,593  0,004  VCAM1 expression inhibitor
0,595  0,009  UGT1A6 substrate
0,583  0,004  Diabetic nephropathy treatment
0,585  0,018  Antihypercholesterolemic
0,579  0,022  Antiparkinsonian
0,563  0,006  Genotoxic
0,545  0,004  Pneumotoxic
0,553  0,011  Antiamyloidogenic
0,542  0,002  Nitric-oxide synthase stimulant
0,547  0,009  Vasodilator
0,556  0,020  Antineoplastic (ovarian cancer)
0,539  0,009  Antineoplastic (glioblastoma multiforme)
0,551  0,026  Aldehyde oxidase inhibitor
0,536  0,016  Apoptosis antagonist
0,530  0,013  Antipyretic
0,531  0,017  UGT1A9 substrate
0,534  0,023  Antipruritic, allergic
0,546  0,035  TNF expression inhibitor
0,508  0,006  Cyclic AMP phosphodiesterase inhibitor
0,520  0,019  CYP2C19 inhibitor
0,510  0,010  Antidiabetic symptomatic
0,515  0,021  Antineoplastic (cervical cancer)
0,496  0,004  Estrogen agonist
0,496  0,007  Topoisomerase II inhibitor
0,493  0,011  Antimutagenic
0,522  0,044  Cyclophilin D inhibitor
0,522  0,044  Antidiabetic
0,492  0,021  Cytostatic
0,494  0,025  Cytotoxic
0,488  0,024  Hepatic disorders treatment
0,481  0,023  Antineoplastic (pancreatic cancer)
0,529  0,072  Alpha-glucosidase inhibitor
0,473  0,020  Antiprotozoal (Leishmania)
0,458  0,009  Melanin inhibitor
0,453  0,007  Amylase inhibitor
0,465  0,022  Antineoplastic (non-small cell lung cancer)
0,448  0,005  Glutathione S-transferase substrate
0,463  0,022  Proliferative diseases treatment
0,465  0,024  Lipoxygenase inhibitor
0,444  0,003  Carcinogenic, group 2A
0,445  0,007  GST M1-1 substrate
0,441  0,006  UGT2B15 substrate
0,449  0,020  UGT2B4 substrate
0,458  0,029  Antineoplastic (melanoma)
0,438  0,010  Skin whitener
0,427  0,004  Histone deacetylase stimulant
0,427  0,004  Histone deacetylase SIRT1 stimulant
0,434  0,011  Hepatoprotectant
0,429  0,010  Tubulin antagonist
0,437  0,031  AR expression inhibitor
0,417  0,015  UGT1A1 substrate
0,403  0,005  Cystathionine beta-synthase inhibitor
0,410  0,013  5 Hydroxytryptamine uptake stimulant
0,407  0,011  Antineoplastic (squamous cell carcinoma)
0,397  0,005  Carcinogenic, group 1
0,439  0,053  CYP3A4 substrate
0,415  0,030  Sensitization
0,411  0,029  Mutagenic
0,394  0,025  Antineoplastic (renal cancer)
0,376  0,008  Antidiarrheal
0,388  0,022  Antineoplastic (small cell lung cancer)
0,414  0,051  Vasodilator, peripheral
0,409  0,048  Antiallergic
0,422  0,060  GST A substrate
0,422  0,064  Histamine release inhibitor
0,358  0,003  Estrogen receptor beta agonist
0,408  0,054  CYP2C9 inhibitor
0,378  0,026  Vascular (periferal) disease treatment
0,390  0,040  Analeptic
0,365  0,015  UGT2B7 substrate
0,368  0,020  Antineoplastic (sarcoma)
0,380  0,033  DNA damaging
0,376  0,029  Amyloid beta aggregation inhibitor
0,415  0,070  Antibacterial
0,344  0,008  Topoisomerase I inhibitor
0,359  0,027  Antineoplastic (lymphocytic leukemia)
0,373  0,046  NOS3 expression inhibitor
0,339  0,016  UGT1A3 substrate
0,369  0,047  Vasodilator, coronary
0,387  0,067  CYP2C9 substrate
0,366  0,047  CYP2C19 substrate
0,333  0,013  NOS3 expression enhancer
0,360  0,047  CTGF expression inhibitor
0,350  0,037  Antineoplastic (lymphoma)
0,357  0,045  Calcium channel activator
0,345  0,034  Antiparasitic
0,358  0,049  CYP1A2 substrate
0,347  0,038  Hypoglycemic
0,355  0,048  Antiosteoporotic
0,335  0,028  UDP-glucuronosyltransferase substrate
0,332  0,025  Antihelmintic
0,309  0,005  Beta amyloid protein antagonist
0,375  0,071  Ulceration
0,321  0,019  Antipruritic, non-allergic
0,321  0,019  Antineoplastic (carcinoma)
0,327  0,032  Peroxidase inhibitor
0,299  0,005  Estrogen receptor beta antagonist
0,349  0,055  Antiischemic
0,356  0,064  Bone diseases treatment
0,304  0,012  Antineoplastic (bone cancer)
0,337  0,047  Chemoprotective
0,304  0,017  Neurotrophic factor enhancer
0,288  0,007  Estrogen antagonist
0,289  0,008  Topoisomerase II alpha inhibitor
0,308  0,027  P-glycoprotein inhibitor
0,361  0,081  Immunosuppressant
0,353  0,076  Stroke treatment
0,282  0,007  UGT2B10 substrate
0,310  0,036  Antihypertriglyceridemic
0,387  0,113  Antineoplastic (solid tumors)
0,331  0,060  CYP3A4 inhibitor
0,301  0,030  Antihypotensive
0,281  0,012  5-Lipoxygenase inhibitor
0,288  0,020  Lipid peroxidase inhibitor
0,330  0,063  Respiratory analeptic
0,283  0,020  Monophenol monooxygenase inhibitor
0,273  0,013  LDLR expression enhancer
0,296  0,036  Abortion inducer
0,275  0,016  Acetylcholinesterase inhibitor
0,311  0,055  Antihypoxic
0,277  0,023  Cholinergic
0,257  0,011  Antibacterial (Helicobacter pylori)
0,255  0,010  UGT2B1 substrate
0,252  0,008  Beta glucuronidase inhibitor
0,251  0,009  Microtubule formation inhibitor
0,258  0,016  Antifungal enhancer
0,260  0,019  Succinate dehydrogenase inhibitor
0,295  0,057  Radiosensitizer
0,260  0,032  Mcl-1 antagonist
0,296  0,069  Antineoplastic (multiple myeloma)
0,246  0,021  GST P1-1 substrate
0,283  0,059  Antineoplastic (liver cancer)
0,273  0,050  Psychostimulant
0,244  0,022  UGT2B9 substrate
0,293  0,076  Antineoplastic (osteosarcoma)
0,246  0,033  Acaricide
0,302  0,090  Cholesterol antagonist
0,226  0,016  Expectorant
0,283  0,074  Hypoxia-inducible factor 1 alpha inhibitor
0,216  0,010  Mucolytic
0,248  0,043  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,207  0,004  Estrogen receptor alpha agonist
0,250  0,049  RNA-directed DNA polymerase inhibitor
0,292  0,092  FMO1 substrate
0,242  0,043  UGT1A4 substrate
0,274  0,076  Antidiabetic (type 2)
0,218  0,022  Alkylator
0,214  0,021  Arachidonic acid antagonist
0,230  0,038  Antihelmintic (Nematodes)
0,261  0,069  Embryotoxic
0,245  0,054  ErbB-1 antagonist
0,327  0,136  5 Hydroxytryptamine release inhibitor
0,221  0,031  VEGF expression inhibitor
0,284  0,094  Sodium/bile acid cotransporter inhibitor
0,259  0,069  Superoxide dismutase inhibitor
0,259  0,074  Teratogen
0,238  0,055  Sedative
0,276  0,093  CYP2D6 substrate
0,264  0,084  Radioprotector
0,260  0,080  CYP1A2 inhibitor
0,215  0,036  Interferon gamma antagonist
0,197  0,019  Alpha 2c adrenoreceptor antagonist
0,235  0,057  Anesthetic general
0,251  0,074  Tumour necrosis factor alpha release inhibitor
0,203  0,027  DNA polymerase I inhibitor
0,203  0,029  SULT1A3 substrate
0,198  0,025  Antitussive
0,211  0,039  Antiparkinsonian, tremor relieving
0,245  0,073  Tyrosine 3 hydroxylase inhibitor
0,215  0,048  Prostatic (benign) hyperplasia treatment
0,240  0,075  Angiogenesis stimulant
0,174  0,010  Macrophage migration inhibitory factor inhibitor
0,201  0,037  Antirickettsial
0,172  0,010  Beta tubulin antagonist
0,251  0,089  Lipoprotein disorders treatment
0,179  0,017  Alpha 2a adrenoreceptor antagonist
0,190  0,029  Toll-Like receptor 2 antagonist
0,263  0,102  12-Lipoxygenase inhibitor
0,186  0,026  Antihemorrhagic
0,290  0,131  Antiprotozoal
0,179  0,019  Gastritis treatment
0,184  0,025  Cyclooxygenase 3 inhibitor
0,222  0,063  Carcinogenic
0,167  0,008  Alpha tubulin antagonist
0,219  0,063  Antiviral (Influenza)
0,165  0,010  UGT2B11 substrate
0,167  0,012  Keratolytic
0,168  0,014  Ca2+-transporting ATPase inhibitor
0,190  0,037  Skin irritative effect
0,227  0,079  Hypolipemic
0,153  0,006  Glycine receptor agonist
0,260  0,114  Antihypertensive
0,167  0,021  Antineoplastic (uterine cancer)
0,157  0,011  Postmenopausal disorders treatment
0,177  0,033  Cholesterol synthesis inhibitor
0,158  0,015  Acetylcholine M3 receptor agonist
0,166  0,024  Alpha 2 adrenoreceptor antagonist
0,164  0,023  Sulfotransferase substrate
0,173  0,032  Adenylate cyclase stimulant
0,200  0,060  Antiviral (Hepatitis)
0,184  0,048  Protein kinase stimulant
0,152  0,019  Antifungal (Pneumocystis)
0,201  0,068  DNA methyltransferase I inhibitor
0,262  0,132  Antineoplastic (endocrine cancer)
0,189  0,060  Antineoplastic (gastric cancer)
0,146  0,017  Paget's disease treatment
0,162  0,034  Carcinogenic, group 2B
0,154  0,027  Carbonic anhydrase III inhibitor
0,133  0,006  Topoisomerase II beta inhibitor
0,197  0,073  Platelet adhesion inhibitor
0,142  0,023  Actinic keratosis treatment
0,180  0,062  Toxic, respiratory center
0,199  0,081  Platelet aggregation inhibitor
0,148  0,031  Antineoplastic antibiotic
0,266  0,149  Atherosclerosis treatment
0,138  0,023  GST T1-1 substrate
0,146  0,033  Bronchodilator
0,141  0,029  HIV-1 integrase (Overall Integration) inhibitor
0,115  0,006  Kinesin antagonist
0,115  0,006  Kinesin-like protein 1 inhibitor
0,138  0,030  Creatine kinase inhibitor
0,142  0,034  AMP-activated protein kinase stimulant
0,148  0,040  Vanilloid 1 agonist
0,173  0,067  Aldehyde oxidase substrate
0,124  0,019  Dopamine D1 antagonist
0,219  0,114  Antineurogenic pain
0,141  0,036  Antiviral (Influenza B)
0,135  0,031  Electron transport complex I inhibitor
0,177  0,073  Lipocortins synthesis antagonist
0,175  0,072  Tumour necrosis factor antagonist
0,189  0,086  DNA methylase inhibitor
0,142  0,039  SULT1A1 substrate
0,159  0,057  Mannose-6-phosphate isomerase inhibitor
0,237  0,136  Antithrombotic
0,158  0,057  MAP kinase 3 inhibitor
0,137  0,038  HDL-cholesterol increasing
0,163  0,064  Antiviral (Influenza A)
0,229  0,130  Mood disorders treatment
0,222  0,124  Antidepressant
0,156  0,060  Skeletal muscle relaxant
0,115  0,019  Thioredoxin reductase inhibitor
0,123  0,027  NADH dehydrogenase inhibitor
0,114  0,021  Estrogen receptor alpha antagonist
0,206  0,114  Spasmolytic
0,113  0,021  HIV-1 integrase (3'-Processing) inhibitor
0,162  0,070  Eye irritation, high
0,096  0,004  Melatonin 1 agonist
0,112  0,022  Granulocyte macrophage colony stimulating factor agonist
0,111  0,022  Na+ K+ transporting ATPase inhibitor
0,124  0,035  Prolactin inhibitor
0,220  0,132  Antifungal
0,136  0,047  Contraceptive female
0,138  0,050  Coagulant
0,145  0,058  Alpha-N-acetylglucosaminidase inhibitor
0,110  0,024  Glycine receptor antagonist
0,112  0,026  ATPase (Vacuolar H+) inhibitor
0,159  0,074  Uterine stimulant
0,148  0,064  CNS active muscle relaxant
0,115  0,031  Carbonic anhydrase VI inhibitor
0,110  0,028  Histidine decarboxylase inhibitor
0,184  0,103  Antialcoholic
0,127  0,047  EphA2 antagonist
0,089  0,009  Postcoital contraceptive
0,139  0,059  Bipolar disorder treatment
0,111  0,033  Carbonic anhydrase XIII inhibitor
0,199  0,122  Antiprotozoal (Trypanosoma)
0,160  0,083  Muscle relaxant
0,092  0,015  Glutamate (mGluR7) antagonist
0,094  0,018  Neuraminidase inhibitor
0,100  0,024  Estrogen-related receptor beta agonist
0,127  0,052  Constipation treatment
0,120  0,045  Urease inhibitor
0,199  0,125  DNA synthesis inhibitor
0,135  0,062  Antiseptic
0,159  0,086  ATPase inhibitor
0,120  0,047  Carbonic anhydrase XV inhibitor
0,096  0,024  HIV-1 integrase (Strand Transfer) inhibitor
0,118  0,047  DOPA decarboxylase inhibitor
0,079  0,008  Alpha 1L adrenoreceptor antagonist
0,107  0,037  Ornithine decarboxylase inhibitor
0,081  0,011  Alpha-mannosidase inhibitor
0,167  0,098  Non-steroidal antiinflammatory agent
0,127  0,058  Protein-tyrosine phosphatase 1B inhibitor
0,101  0,033  Antiprotozoal activity enhancer
0,169  0,101  CYP2B6 inhibitor
0,118  0,051  Multidrug resistance-associated protein 1 inhibitor
0,113  0,046  Anabolic
0,072  0,006  Melatonin agonist
0,171  0,105  Insulin sensitizer
0,113  0,048  UDP-glucose 4-epimerase inhibitor
0,119  0,054  GABA C receptor antagonist
0,145  0,082  Antiviral (Herpes)
0,080  0,017  Transcription factor RelA inhibitor
0,146  0,083  Protein-tyrosine phosphatase inhibitor
0,087  0,025  Aromatase inhibitor
0,129  0,069  Antihelmintic (Trematoda)
0,138  0,079  Pregnane X receptor agonist
0,082  0,023  SULT2A1 substrate
0,064  0,005  Sodium/glucose cotransporter 2 inhibitor
0,145  0,086  Neuropathy treatment
0,090  0,031  HIV-1 integrase inhibitor
0,132  0,075  Contraceptive
0,124  0,066  Antiviral (Hepatitis B)
0,081  0,024  Neuraminidase (influenza) inhibitor
0,121  0,064  Alcohol dehydrogenase substrate
0,086  0,029  Secretase beta inhibitor
0,110  0,053  Xanthine oxidase inhibitor
0,086  0,030  Antitreponemal
0,090  0,034  Lipase inhibitor
0,089  0,034  Narcotic antagonist
0,101  0,046  Androgen antagonist
0,163  0,109  Cardiodepressant
0,058  0,005  Tubulin agonist
0,094  0,041  NAD(P)H dehydrogenase (quinone) inhibitor
0,250  0,198  Antiarthritic
0,100  0,049  Alpha 2d adrenoreceptor antagonist
0,137  0,086  Antidote
0,064  0,014  Mannosidase inhibitor
0,077  0,028  Glutamate (mGluR6) antagonist
0,107  0,059  Toll-Like receptor 4 antagonist
0,099  0,051  Bile acid receptor antagonist
0,062  0,013  Dopamine D3 agonist
0,066  0,018  Glucose-6-phosphate translocase inhibitor
0,074  0,027  Androgen agonist
0,122  0,075  Papain-like protease (SARS coronavirus) inhibitor
0,083  0,036  Leukotriene synthesis inhibitor
0,064  0,019  Anesthetic inhalation
0,060  0,014  Microtubule stabilization
0,072  0,026  Aldose reductase inhibitor
0,050  0,005  Sodium/glucose cotransporter inhibitor
0,137  0,092  GABA C receptor rho-2 antagonist
0,056  0,013  Glucocorticoid antagonist
0,057  0,014  Guanylate cyclase inhibitor
0,177  0,135  Immunostimulant
0,153  0,111  Phobic disorders treatment
0,128  0,086  Farnesoid X receptor antagonist
0,092  0,054  Antidote, mercury
0,106  0,068  DNA intercalator
0,080  0,041  Phosphofructokinase-1 inhibitor
0,052  0,014  Hypogonadism treatment
0,116  0,080  DNA repair enzyme inhibitor
0,068  0,032  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,091  0,054  Antineoplastic alkaloid
0,062  0,026  Acetylcholine M2 receptor agonist
0,069  0,033  Antimycoplasmal
0,117  0,083  Cyclooxygenase 1 inhibitor
0,108  0,075  Photosensitizer
0,050  0,017  Dopamine D5 agonist
0,074  0,042  Alpha adrenoreceptor agonist
0,049  0,018  Progesterone antagonist
0,055  0,024  Potassium channel Kv1.3 blocker
0,122  0,091  Antianorexic
0,133  0,103  MAP kinase kinase 4 inhibitor
0,133  0,103  Heat shock protein 70 antagonist
0,036  0,007  Sodium/glucose cotransporter 1 inhibitor
0,110  0,082  Growth stimulant
0,051  0,023  Neuraminidase (Influenza A) inhibitor
0,199  0,171  Angiogenesis inhibitor
0,061  0,035  Ryanodine receptor antagonist
0,128  0,103  Phospholipase A2 inhibitor
0,053  0,029  Squalene epoxidase inhibitor
0,039  0,015  Nucleoside transporters inhibitor
0,051  0,028  Glucose-6-phosphate isomerase inhibitor
0,070  0,047  Anticholelithogenic
0,076  0,052  SULT1A2 substrate
0,044  0,022  Kainate receptor agonist
0,088  0,067  Glutamate release inhibitor
0,059  0,038  Lipocortins synthesis agonist
0,113  0,092  NADPH oxidase inhibitor
0,041  0,020  Glutamate (mGluR8) agonist
0,088  0,068  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,082  0,062  Calcium antagonist
0,057  0,038  Pregnane X receptor antagonist
0,073  0,053  Antibiotic
0,047  0,027  Dopamine D5 antagonist
0,055  0,036  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,087  0,070  Antiviral (Hepatitis A)
0,110  0,093  Phosphodiesterase inhibitor
0,082  0,064  mTOR complex 2 inhibitor
0,034  0,018  Glutamate (mGluR3) agonist
0,039  0,024  Vanilloid 3 antagonist
0,235  0,222  Calcium channel L-type activator
0,062  0,049  Calcium channel P-type blocker
0,020  0,007  NMDA receptor phencyclidine site antagonist
0,095  0,082  Antihelmintic (Fasciola)
0,130  0,118  CF transmembrane conductance regulator agonist
0,081  0,068  Transcription factor NF kappa B stimulant
0,077  0,065  Glutathione S-transferase inhibitor
0,078  0,066  Ca(v)3.1 blocker
0,024  0,013  Prostaglandin F2 alpha agonist
0,099  0,089  Acetylcholine release stimulant
0,100  0,091  Antiviral (SARS coronavirus)
0,100  0,091  Antiviral (Coronavirus)
0,129  0,119  Prostate disorders treatment
0,054  0,044  Fatty acid synthase inhibitor
0,075  0,067  Antidote, organophosphates
0,053  0,045  Alpha 1 adrenoreceptor agonist
0,088  0,080  Chronic obstructive bronchitis treatment
0,032  0,025  Sodium-dependent vitamin C transporter 2 inhibitor
0,023  0,015  Dopamine D1 agonist
0,190  0,183  FMO3 substrate
0,130  0,123  Antiviral (Hepatitis C)
0,066  0,060  Glutamate decarboxylase inhibitor
0,091  0,086  Choleretic
0,120  0,115  Sigma receptor agonist
0,097  0,092  Proteasome inhibitor
0,036  0,031  Glucose-6-phosphate dehydrogenase inhibitor
0,078  0,074  D-Ala-D-Ala ligase inhibitor
0,046  0,041  HCV NS3/NS4A protease inhibitor
0,053  0,049  Leukotriene C antagonist
0,073  0,069  MAP kinase kinase 7 inhibitor
0,074  0,070  Antispirochetal
0,077  0,074  Alpha adrenoreceptor antagonist
0,018  0,015  Antibiotic Anthracycline-like
0,078  0,075  Vanilloid agonist
0,063  0,061  MDM2 inhibitor
0,011  0,009  Glutamate (mGluR6) agonist
0,128  0,126  Antipruritic
0,030  0,029  Estrogen-related receptor beta antagonist
0,048  0,047  Alcohol oxidase inhibitor
0,039  0,038  Cholesterol absorption inhibitor

